Belano, Manilyn S.

HRN: 27-16-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2025
CEFUROXIME 750MG (VIAL)
11/09/2025
11/15/2025
IV
750mg
PTOR Then Q8
Anterior Neck Mass, For OR
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: